Healthcare provider profile · identity verified

Scott F Young, MD

Family Practice · WAYNESBORO, VA · NPI 1144211459

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	466	144
Omeprazole	Omeprazole	453	127
Levothyroxine Sodium	Levothyroxine Sodium	438	114
Amlodipine Besylate	Amlodipine Besylate	353	107
Hydrochlorothiazide	Hydrochlorothiazide	349	101
Atorvastatin Calcium	Atorvastatin Calcium	339	107
Losartan Potassium	Losartan Potassium	326	87
Metformin Hcl	Metformin Hcl	273	75
Rosuvastatin Calcium	Rosuvastatin Calcium	268	78
Pravastatin Sodium	Pravastatin Sodium	236	67
Simvastatin	Simvastatin	235	66
Gabapentin	Gabapentin	207	57
Metoprolol Tartrate	Metoprolol Tartrate	178	54
Pantoprazole Sodium	Pantoprazole Sodium	176	57
Sertraline Hcl	Sertraline Hcl	160	50
Metoprolol Succinate	Metoprolol Succinate	159	45
Glipizide	Glipizide	130	33
Eliquis	Apixaban	126	28
Furosemide	Furosemide	119	39
Trazodone Hcl	Trazodone Hcl	115	35
Escitalopram Oxalate	Escitalopram Oxalate	114	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	114	24
Warfarin Sodium	Warfarin Sodium	112	33
Tramadol Hcl	Tramadol Hcl	105	20
Alprazolam	Alprazolam	104	18
Metformin Hcl Er	Metformin Hcl	103	33
Buspirone Hcl	Buspirone Hcl	102	27
Famotidine	Famotidine	100	34
Potassium Chloride	Potassium Chloride	100	34
Allopurinol	Allopurinol	94	27
Albuterol Sulfate Hfa	Albuterol Sulfate	86	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	27
Tamsulosin Hcl	Tamsulosin Hcl	77	27
Glipizide Er	Glipizide	76	21
Zolpidem Tartrate	Zolpidem Tartrate	69	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	68	16
Duloxetine Hcl	Duloxetine Hcl	67	18
Amitriptyline Hcl	Amitriptyline Hcl	62	17
Carvedilol	Carvedilol	61	19
Fluticasone Propionate	Fluticasone Propionate	61	26
Montelukast Sodium	Montelukast Sodium	61	17
Ropinirole Hcl	Ropinirole Hcl	60	16
Clopidogrel	Clopidogrel Bisulfate	58	19
Synthroid	Levothyroxine Sodium	56	17
Cephalexin	Cephalexin	53	46
Ezetimibe	Ezetimibe	52	suppressed
Atenolol	Atenolol	50	17
Clonazepam	Clonazepam	50	suppressed
Meclizine Hcl	Meclizine Hcl	50	20
Oxycodone Hcl	Oxycodone Hcl	47	12
Bupropion Hcl Sr	Bupropion Hcl	44	16
Lorazepam	Lorazepam	44	suppressed
Baclofen	Baclofen	43	14
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	12
Spironolactone	Spironolactone	41	14
Citalopram Hbr	Citalopram Hydrobromide	40	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	31
Finasteride	Finasteride	37	13
Klor-Con M10	Potassium Chloride	37	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	11
Lovastatin	Lovastatin	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Diclofenac Sodium	Diclofenac Sodium	31	11
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Prednisone	Prednisone	23	13
Alendronate Sodium	Alendronate Sodium	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Ozempic	Semaglutide	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Temazepam	Temazepam	16	suppressed
Nystatin	Nystatin	15	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Azithromycin	Azithromycin	14	13
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Topiramate	Topiramate	12	suppressed
Acebutolol Hcl	Acebutolol Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error